Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07204249) titled 'Glutide for Ending Methamphetamine' on Sept. 24.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: San Francisco Department of Public Health
Condition:
Methamphetamine-dependence
Intervention:
Drug: Semaglutide
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: January 15, 2026
Target Sample Size: 25
To know more, visit https://clinicaltrials.gov/study/NCT07204249
Published by HT Digital Content Services with permission from Health Daily Digest....